Literature DB >> 893601

Simple sensitive and specific gas chromatographic method for the quantification of diltiazem human body fluids.

V Rovel, M Mitchard, P L Morselli.   

Abstract

A gas cromatographic method for the determination of the benzothiazepine diltiazem together with its major metabolite desacetydilitiazem, is described. Silylation of the desacetyl derivative separates the metabolite from the parent drug on a 1% OV-17 column and cyclopam is used as an internal reference standard. The compounds are analysed by means of a nitrogen detector which allows the determination of 10 ng/ml of both compounds in plasma. The method has been used to determine both diltiazem and its desacetyl derivative in plasma obtained from healthy volunteers after oral doses of 60-210 mg of diltiazem.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893601     DOI: 10.1016/s0021-9673(00)94974-4

Source DB:  PubMed          Journal:  J Chromatogr


  12 in total

Review 1.  Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 2.  Clinical pharmacokinetics of calcium antagonists. An update.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

3.  A haemodynamic and radionuclide assessment of diltiazem in coronary heart disease.

Authors:  B Silke; S K Sharma; S P Verma; K A Midtbo; G Reynolds; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

4.  Haemodynamic effects of diltiazem in healthy volunteers.

Authors:  H Valette; E Apoil
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

5.  Effect of diltiazem on plasma glucose, insulin and glucagon during an oral glucose tolerance test in healthy volunteers.

Authors:  J M Segrestaa; C Caulin; R Dahan; D Houlbert; J F Thiercelin; P Herman; J P Sauvanet; J Larribaud
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pharmacokinetics of diltiazem after intravenous and oral administration.

Authors:  P Hermann; S D Rodger; G Remones; J P Thenot; D R London; P L Morselli
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  The peripheral vascular effects of diltiazem--dose-response characteristics.

Authors:  M B Finch; G D Johnston
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

Review 8.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

9.  Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies.

Authors:  W Homsy; M Lefebvre; G Caillé; P du Souich
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

10.  Pharmacokinetics of diltiazem in severe renal failure.

Authors:  N Pozet; J L Brazier; A H Aïssa; D Khenfer; G Faucon; E Apoil; J Traeger
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.